临床经验
Copyright ©The Author(s) 2012.
世界华人消化杂志. 2012-08-28; 20(24): 2296-2301
在线出版 2012-08-28. doi: 10.11569/wcjd.v20.i24.2296
表3 肝硬化放疗组、介入组及肝癌放疗组治疗前后WBC、HGB及PLT的变化
治疗前治疗中治疗后 治疗中最低值P1P2P3
WBC(×109/L)
肝硬化放疗组2.64±0.965.27±1.386.04±1.592.14±0.540.0310.0000.34
介入组4.03±3.325.72±2.075.19±1.562.91±1.670.0420.0480.152
肝癌放疗组2.01±0.875.41±1.565.53±1.472.09±0.640.0010.0000.76
P40.1520.5710.4800.175
Hb(g/L)
肝硬化放疗组111.28±18.56130.00±12.31132.33±19.21110.81±18.450.0270.0210.062
介入组115.09±29.50112.26±26.94101.61±51.78103.18±32.130.7120.0530.057
肝癌放疗组101.34±21.37124±16.71111.19±38.2198.27±27.140.0180.0610.381
P40.6710.6600.4140.472
PLT(×1012/L)
肝硬化放疗组44.85±21.7866.70±27.1195.76±68.3827.72±12.810.0240.0030.042
介入组68.48±47.4394.53±101.5887.88±47.6941.52±28.880.0270.0380.019
肝癌放疗组41.38±22.1074.30±41.2191±56.3330.67±17.310.0160.0000.217
P40.2310.4700.8740.141

引文著录: 王丽娜, 何津祥, 靳炘, 刘兆辰, 李丰旭. 放射治疗与介入治疗肝源性脾亢75例. 世界华人消化杂志 2012; 20(24): 2296-2301